Myocardial Ischaemic Syndrome: Clinical Trials

1 trial for Myocardial Ischaemic Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Not yet recruiting 1

Follow Myocardial Ischaemic Syndrome: new trials by email Literature Review of Myocardial Ischaemic Syndrome trials Research Report on Myocardial Ischaemic Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Protective Effect of PCSK9 Inhibitor Against Negative Inflammatory Response and Organ Dysfunction After Coronary Artery Bypass Grafting (PANDA VIII)
PCSK9 inhibitor, Statin - Myocardial Ischaemic Syndrome, Coronary Heart Disease
Not applicableNot yet recruitingNanjing Medical University4002025-01-012024-12-12

Narrower conditions

Coronary Disease (1)  ·  Inflammation (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Myocardial Ischemia (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Vascular Diseases (1)

Interventions

Hydroxymethylglutaryl-CoA Reductase Inhibitors (1)

Sponsors

Nanjing Medical University (1)

Countries

China (1)

Top investigators

Lu-yao Ma, MD (1)

Results publications

PMID 33197560, PMID 35606883, PMID 38337601